# Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis

> **NCT01728727** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Air Force Military Medical University, China** · enrollment: 240 (estimated)

## Conditions studied

- Liver Cirrhosis
- End Stage Liver Disease

## Interventions

- **OTHER:** UC-MSC transplantation
- **OTHER:** conventional treatment

## Key facts

- **NCT ID:** NCT01728727
- **Lead sponsor:** Air Force Military Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2014-09
- **Final completion:** 2015-09
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2012-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728727, "Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01728727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*